OFK-Cardio is a privately held Russian company specializing in development and production of test systems for the early diagnosis of myocardial infarction.
The competitive advantages of the company are the following:
— scientific-research works aimed at developing new methods of express diagnostic by immunoassay methods,
— organization of the complete cycle of test systems production.
In 2009 the company became the winner of the START-09 contest organized by the Fund for Assistance to Small Innovative Enterprises in the scientific and technical industry.
OFK-Cardio has been developing test systems for the early detection of myocardial infarction for more than 3 years. During this period the company has conducted full range of works in R&D, experimental design, preparation of the production facility, and intellectual property protection.
Today the company develops new improved test systems by adding supplemental features and characteristics.
The information provided about the company is relevant at the time of the exhibition